Advanced search
1 file | 1.17 MB Add to list

Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go

Author
Organization
Project
Abstract
Phage lysins are one of the most advanced classes of antibacterials under clinical evaluation and have a new mode of action based on peptidoglycan degradation. Lysins were initially excluded from use against Gram-negative pathogens because of their impermeable outer membrane, but are now increasingly developed as effective antibacterials against these critical priority pathogens. Generally, three routes of investigation have been recently explored and advanced to different extents, including the use of lysins that possess intrinsic activity due to a positively charged C-terminus that destabilizes the outer membrane, the use of physical or chemical means to disrupt the outer membrane integrity and protein engineering to equip the lysin with the necessary tools to overcome the outer membrane.
Keywords
ESCHERICHIA-COLI, PHAGE LYSIN, ACINETOBACTER-BAUMANNII, PSEUDOMONAS-AERUGINOSA, ANTIBACTERIAL ACTIVITY, RESISTANT, ENDOLYSIN, ART-175, PERMEABILITY, PEPTIDES

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.17 MB

Citation

Please use this url to cite or link to this publication:

MLA
Gutierrez Fernandez, Diana, and Yves Briers. “Lysins Breaking down the Walls of Gram-Negative Bacteria, No Longer a No-Go.” CURRENT OPINION IN BIOTECHNOLOGY, vol. 68, 2021, pp. 15–22, doi:10.1016/j.copbio.2020.08.014.
APA
Gutierrez Fernandez, D., & Briers, Y. (2021). Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go. CURRENT OPINION IN BIOTECHNOLOGY, 68, 15–22. https://doi.org/10.1016/j.copbio.2020.08.014
Chicago author-date
Gutierrez Fernandez, Diana, and Yves Briers. 2021. “Lysins Breaking down the Walls of Gram-Negative Bacteria, No Longer a No-Go.” CURRENT OPINION IN BIOTECHNOLOGY 68: 15–22. https://doi.org/10.1016/j.copbio.2020.08.014.
Chicago author-date (all authors)
Gutierrez Fernandez, Diana, and Yves Briers. 2021. “Lysins Breaking down the Walls of Gram-Negative Bacteria, No Longer a No-Go.” CURRENT OPINION IN BIOTECHNOLOGY 68: 15–22. doi:10.1016/j.copbio.2020.08.014.
Vancouver
1.
Gutierrez Fernandez D, Briers Y. Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go. CURRENT OPINION IN BIOTECHNOLOGY. 2021;68:15–22.
IEEE
[1]
D. Gutierrez Fernandez and Y. Briers, “Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go,” CURRENT OPINION IN BIOTECHNOLOGY, vol. 68, pp. 15–22, 2021.
@article{8677572,
  abstract     = {{Phage lysins are one of the most advanced classes of antibacterials under clinical evaluation and have a new mode of action based on peptidoglycan degradation. Lysins were initially excluded from use against Gram-negative pathogens because of their impermeable outer membrane, but are now increasingly developed as effective antibacterials against these critical priority pathogens. Generally, three routes of investigation have been recently explored and advanced to different extents, including the use of lysins that possess intrinsic activity due to a positively charged C-terminus that destabilizes the outer membrane, the use of physical or chemical means to disrupt the outer membrane integrity and protein engineering to equip the lysin with the necessary tools to overcome the outer membrane.}},
  author       = {{Gutierrez Fernandez, Diana and Briers, Yves}},
  issn         = {{0958-1669}},
  journal      = {{CURRENT OPINION IN BIOTECHNOLOGY}},
  keywords     = {{ESCHERICHIA-COLI,PHAGE LYSIN,ACINETOBACTER-BAUMANNII,PSEUDOMONAS-AERUGINOSA,ANTIBACTERIAL ACTIVITY,RESISTANT,ENDOLYSIN,ART-175,PERMEABILITY,PEPTIDES}},
  language     = {{eng}},
  pages        = {{15--22}},
  title        = {{Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go}},
  url          = {{http://doi.org/10.1016/j.copbio.2020.08.014}},
  volume       = {{68}},
  year         = {{2021}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: